|
Volumn 118, Issue 12, 2005, Pages 1312-1313
|
Clinical opinion prevails over the pneumonia severity index
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
INFLUENZA VACCINE;
PNEUMOCOCCUS VACCINE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANTIBIOTIC THERAPY;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
COMMUNITY ACQUIRED PNEUMONIA;
COMORBIDITY;
CONSENSUS DEVELOPMENT;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
EDITORIAL;
HUMAN;
INFECTION RATE;
INFECTION RISK;
MEDICAL DECISION MAKING;
MORTALITY;
PATIENT COMPLIANCE;
PATIENT MONITORING;
PREDICTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SCREENING TEST;
DECISION SUPPORT SYSTEMS, CLINICAL;
HUMANS;
PATIENT CARE PLANNING;
PNEUMONIA;
SEVERITY OF ILLNESS INDEX;
|
EID: 29244433499
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjmed.2005.08.053 Document Type: Editorial |
Times cited : (6)
|
References (6)
|